CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
153 hedge funds and large institutions have $220M invested in Clovis Oncology, Inc. in 2020 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $358M → $220M (-$138M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
153
Holding in Top 10
1
Calls
$61.7M
Puts
$29.6M
Top Buyers
| 1 | +$6.2M | |
| 2 | +$6.14M | |
| 3 | +$3.81M | |
| 4 |
CAC
Cowen and Company
New York
|
+$2.96M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.62M |
Top Sellers
| 1 | -$35.9M | |
| 2 | -$3.27M | |
| 3 | -$2.67M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.49M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.48M |